• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体/共激活因子识别的结构基础以及他莫昔芬对这种相互作用的拮抗作用。

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

作者信息

Shiau A K, Barstad D, Loria P M, Cheng L, Kushner P J, Agard D A, Greene G L

机构信息

Howard Hughes Medical Institute and the Department of Biochemistry and Biophysics, University of California at San Francisco, 94143-0448, USA.

出版信息

Cell. 1998 Dec 23;95(7):927-37. doi: 10.1016/s0092-8674(00)81717-1.

DOI:10.1016/s0092-8674(00)81717-1
PMID:9875847
Abstract

Ligand-dependent activation of transcription by nuclear receptors (NRs) is mediated by interactions with coactivators. Receptor agonists promote coactivator binding, and antagonists block coactivator binding. Here we report the crystal structure of the human estrogen receptor alpha (hER alpha) ligand-binding domain (LBD) bound to both the agonist diethylstilbestrol (DES) and a peptide derived from the NR box II region of the coactivator GRIP1 and the crystal structure of the hER alpha LBD bound to the selective antagonist 4-hydroxytamoxifen (OHT). In the DES-LBD-peptide complex, the peptide binds as a short alpha helix to a hydrophobic groove on the surface of the LBD. In the OHT-LBD complex, helix 12 occludes the coactivator recognition groove by mimicking the interactions of the NR box peptide with the LBD. These structures reveal the two distinct mechanisms by which structural features of OHT promote this "autoinhibitory" helix 12 conformation.

摘要

核受体(NRs)的配体依赖性转录激活是通过与共激活因子的相互作用介导的。受体激动剂促进共激活因子结合,而拮抗剂则阻断共激活因子结合。在此,我们报告了与激动剂己烯雌酚(DES)以及源自共激活因子GRIP1的NR框II区域的肽结合的人雌激素受体α(hERα)配体结合域(LBD)的晶体结构,以及与选择性拮抗剂4-羟基他莫昔芬(OHT)结合的hERα LBD的晶体结构。在DES-LBD-肽复合物中,该肽以短α螺旋形式结合到LBD表面的疏水凹槽上。在OHT-LBD复合物中,螺旋12通过模拟NR框肽与LBD的相互作用来封闭共激活因子识别凹槽。这些结构揭示了OHT的结构特征促进这种“自抑制性”螺旋12构象的两种不同机制。

相似文献

1
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.雌激素受体/共激活因子识别的结构基础以及他莫昔芬对这种相互作用的拮抗作用。
Cell. 1998 Dec 23;95(7):927-37. doi: 10.1016/s0092-8674(00)81717-1.
2
Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.己烯雌酚或4-羟基他莫昔芬使雌激素相关受体γ失活的结构基础及选择性的决定因素。
J Biol Chem. 2004 Aug 6;279(32):33639-46. doi: 10.1074/jbc.M402195200. Epub 2004 May 24.
3
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.一种亚型选择性配体的结构表征揭示了雌激素受体拮抗作用的新模式。
Nat Struct Biol. 2002 May;9(5):359-64. doi: 10.1038/nsb787.
4
Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.共激活因子肽对雌激素和抗雌激素与雌激素受体的结合具有不同的稳定作用。
Mol Endocrinol. 1999 Nov;13(11):1912-23. doi: 10.1210/mend.13.11.0373.
5
Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.雌激素相关受体3非配体依赖性转录激活的结构和功能证据。
Mol Cell. 2002 Feb;9(2):303-13. doi: 10.1016/s1097-2765(02)00444-6.
6
A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.果蝇雌激素相关受体(ERR)的三重突变体赋予配体诱导的活性抑制作用。
Biochemistry. 2003 Jun 3;42(21):6427-35. doi: 10.1021/bi027279b.
7
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.4-羟基他莫昔芬与雌激素相关受体γ结合并使其失活。
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8880-4. doi: 10.1073/pnas.151244398. Epub 2001 Jul 10.
8
Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.转录中介因子2核受体盒肽与雌激素受体α共激活因子结合位点的相互作用
J Biol Chem. 2002 Jun 14;277(24):21862-8. doi: 10.1074/jbc.M200764200. Epub 2002 Apr 5.
9
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.他莫昔芬与雌激素受体共激活因子识别位点结合的意义。
Endocr Relat Cancer. 2008 Dec;15(4):851-70. doi: 10.1677/ERC-07-0281. Epub 2008 Aug 28.
10
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.雌激素受体α共激活因子结合小分子抑制剂的设计、合成及体外生物学评价
J Med Chem. 2004 Jan 29;47(3):600-11. doi: 10.1021/jm030404c.

引用本文的文献

1
Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha.利用人工智能鉴定蟾毒灵为雌激素受体α的分子胶降解剂。
Nat Commun. 2025 Aug 22;16(1):7854. doi: 10.1038/s41467-025-62288-7.
2
Luminescent Properties and Cytotoxic Activity of 2-phenylbenzoxazole Fluorosulfate Derivatives.2-苯基苯并恶唑氟硫酸盐衍生物的发光性质及细胞毒性活性
Int J Mol Sci. 2025 Jul 27;26(15):7261. doi: 10.3390/ijms26157261.
3
5-(Thiophen-2-yl)isoxazoles as novel anti-breast cancer agents targeting ERα: synthesis, biological evaluation, studies, and molecular dynamics simulation.
5-(噻吩-2-基)异恶唑作为靶向雌激素受体α的新型抗乳腺癌药物:合成、生物学评价、研究及分子动力学模拟
RSC Med Chem. 2025 Jun 25. doi: 10.1039/d5md00339c.
4
Design, synthesis and evaluation of benzodioxole and bromofuran tethered 1,2,4-triazole hybrids as potential anti breast cancer agents with computational insights.苯并二恶唑和溴代呋喃连接的1,2,4-三唑杂化物作为潜在抗乳腺癌药物的设计、合成与评估及计算分析
Sci Rep. 2025 Jul 16;15(1):25680. doi: 10.1038/s41598-025-09420-1.
5
From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.从概念到抑制剂:靶向蛋白质-蛋白质相互作用的蓝图
Chem Rev. 2025 Jul 23;125(14):6819-6869. doi: 10.1021/acs.chemrev.5c00046. Epub 2025 Jun 24.
6
Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).强效且口服生物利用度良好的完全雌激素受体拮抗剂(CERAN)和选择性雌激素受体降解剂(SERD)帕拉泽司琼(OP - 1250)的发现。
ACS Omega. 2025 May 29;10(22):22685-22700. doi: 10.1021/acsomega.4c11023. eCollection 2025 Jun 10.
7
Entropy tree networks of residue dynamics encode protein allostery.残基动力学的熵树网络编码蛋白质变构。
bioRxiv. 2025 May 30:2025.05.28.656549. doi: 10.1101/2025.05.28.656549.
8
A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for Cell-Membrane Permeable Inhibitors for the Interaction Between Estrogen Receptor α and Coactivator SRC1.一种环化螺旋-环-螺旋肽作为雌激素受体α与共激活因子SRC1相互作用的细胞膜可渗透抑制剂的分子支架。
Chembiochem. 2025 Jul 11;26(13):e202500232. doi: 10.1002/cbic.202500232. Epub 2025 Jun 20.
9
27-Hydroxycholesterol in cancer development and drug resistance.27-羟基胆固醇在癌症发生发展及耐药性中的作用
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2507670. doi: 10.1080/14756366.2025.2507670. Epub 2025 May 22.
10
Advances in Mechanochemical Methods for One-Pot Multistep Organic Synthesis.一锅多步有机合成的机械化学方法进展
Chemistry. 2025 Jun 17;31(34):e202500798. doi: 10.1002/chem.202500798. Epub 2025 May 24.